CME Group (CME) Scheduled to Post Quarterly Earnings on Wednesday

CME Group (NASDAQ:CMEGet Free Report) is set to announce its earnings results before the market opens on Wednesday, April 24th. Analysts expect the company to announce earnings of $2.44 per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, topping the consensus estimate of $2.27 by $0.10. The company had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. CME Group’s revenue was up 19.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.92 earnings per share. On average, analysts expect CME Group to post $10 EPS for the current fiscal year and $10 EPS for the next fiscal year.

CME Group Stock Up 0.1 %

Shares of CME opened at $206.48 on Wednesday. The firm has a market cap of $74.33 billion, a P/E ratio of 23.28, a P/E/G ratio of 5.95 and a beta of 0.49. The stock has a 50 day simple moving average of $214.09 and a two-hundred day simple moving average of $211.65. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group has a 1 year low of $175.73 and a 1 year high of $223.80.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were given a $1.15 dividend. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.23%. This is an increase from CME Group’s previous quarterly dividend of $1.10. CME Group’s payout ratio is presently 51.86%.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Barclays upped their target price on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a report on Monday, April 8th. Rosenblatt Securities reiterated a “sell” rating and issued a $180.00 price objective on shares of CME Group in a report on Thursday, January 4th. The Goldman Sachs Group downgraded CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective for the company. in a report on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $210.00 price objective (down previously from $235.00) on shares of CME Group in a report on Friday, April 5th. Finally, Argus increased their price objective on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $215.70.

Read Our Latest Stock Analysis on CME

Institutional Trading of CME Group

Hedge funds have recently modified their holdings of the company. RB Capital Management LLC grew its position in CME Group by 11.4% in the 1st quarter. RB Capital Management LLC now owns 1,419 shares of the financial services provider’s stock valued at $338,000 after acquiring an additional 145 shares during the last quarter. Prudential PLC bought a new position in CME Group in the 1st quarter valued at $1,709,000. Cetera Investment Advisers grew its position in CME Group by 5.8% in the 1st quarter. Cetera Investment Advisers now owns 3,485 shares of the financial services provider’s stock valued at $829,000 after acquiring an additional 190 shares during the last quarter. Sequoia Financial Advisors LLC bought a new position in CME Group in the 1st quarter valued at $281,000. Finally, Candriam Luxembourg S.C.A. grew its position in CME Group by 9.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 25,230 shares of the financial services provider’s stock valued at $6,001,000 after acquiring an additional 2,181 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.